Deal Reports
Data-driven market intelligence for biopharma deal professionals
July 2026
Q2 2026 Biopharma Deal Benchmarks
Institutional-grade quarterly analysis with risk-adjusted phase economics, royalty rate benchmarks, modality cycle tracking, and 4 market themes reshaping dealmaking. From 1,600+ verified transactions.
Quarterly ReportPhase EconomicsRoyalty RatesModality Cycles
March 2026
Q1 2026 Biopharma Deal Benchmarks
Quarterly analysis of deal economics across 13 therapeutic areas. Phase-by-phase benchmarks, deal structure evolution, and 3 market themes. From 1,600+ verified transactions.
Quarterly ReportDeal BenchmarksMarket Themes
March 2026
Life Sciences Deal Trends 2026
Annual market report covering deal volume by therapeutic area, hottest modalities, phase trends, geographic shifts, and 2027 outlook. Data from 1,600+ biopharma transactions.
Annual ReportDeal TrendsMarket Data
Want Custom Analysis?
Pro subscribers get access to detailed quarterly reports with custom filtering by therapeutic area, modality, and deal type.
Try the Calculator